Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Radient has submitted two abstracts and they waited until the very last day allowed for submission. They may have been waiting for better coverage in some sort of journal article but may not have found any journal that would accept the submission. This is essentially a restatement of the Small-Howard article last year and journals only accept new material.